RxDoctor Payments Data

Pasquale Petrera, MD

Adult Reconstructive Orthopaedic Surgery · Salisbury, MDNPI 1215918933

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $118,450 of the $137,001 with a category attached, or 86.5%. Corentec America Inc accounts for 64.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $61,376 and has fallen 97.1% since, to $1,783 in 2025. Among adult reconstructive orthopaedic surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$137,001in general payments, 2019–2025

Across 125 payments — averaging $1096.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corentec America Inc$88K
  • Globus Medical$45K
  • Stryker$2K
  • Arthrex$884
  • Supreme Orthopedic Systems, LLC$695
  • Smith+Nephew$268
  • plus $418 from 3 others
$250in research payments, 2019–2025

Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$250

What the payments were for

  • Royalty or licence$3,4323%
  • Consulting fees$118,45086%
  • Travel & lodging$11,0628%
  • Food & beverage$3,2932%
  • Education$7641%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$137,001 in reported general payments places this provider in the 90th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.

See all adult reconstructive orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$438,378
Medicare patients
1,348
Services billed
8,637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Etodolac85$1,789
Etodolac ErEtodolac12$835
Tramadol Hcl55$219
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$180
Meloxicam33$122
Amoxicillin84$76
Azithromycin13$45

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Salisbury

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →